Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism
Clostridioides difficile infection (CDI) results in significant morbidity and mortality in hospitalised patients. Here the authors engineer probiotics to restore intestinal bile salt metabolism in response to antibiotic-induced microbiome dysbiosis significantly inhibit Clostridioides difficile infe...
Main Authors: | Elvin Koh, In Young Hwang, Hui Ling Lee, Ryan De Sotto, Jonathan Wei Jie Lee, Yung Seng Lee, John C. March, Matthew Wook Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-31334-z |
Similar Items
-
Consortium of Probiotics Attenuates Colonization of Clostridioides difficile
by: Xianping Li, et al.
Published: (2019-12-01) -
Unveiling the inhibition mechanism of Clostridioides difficile by Bifidobacterium longum via multiomics approach
by: Sung-Hyun Jo, et al.
Published: (2023-11-01) -
Inhibition of selenoprotein synthesis is not the mechanism by which auranofin inhibits growth of Clostridioides difficile
by: Michael A. Johnstone, et al.
Published: (2023-09-01) -
2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
by: Maria Wiese, et al.
Published: (2022-10-01) -
Role of probiotics in preventing Clostridioides difficile infection in older adults: an integrative review
by: Maria Lucianny Lima Barbosa, et al.
Published: (2023-08-01)